1. Home
  2. SUPN vs APLE Comparison

SUPN vs APLE Comparison

Compare SUPN & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$45.64

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Apple Hospitality REIT Inc.

APLE

Apple Hospitality REIT Inc.

HOLD

Current Price

$11.68

Market Cap

2.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
APLE
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
SUPN
APLE
Price
$45.64
$11.68
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$63.25
$14.17
AVG Volume (30 Days)
739.6K
2.5M
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
8.69%
EPS Growth
N/A
N/A
EPS
N/A
0.74
Revenue
$681,539,000.00
$1,418,986,000.00
Revenue This Year
$8.32
$0.53
Revenue Next Year
$23.36
$2.22
P/E Ratio
N/A
$15.80
Revenue Growth
4.54
0.57
52 Week Low
$29.16
$10.44
52 Week High
$57.65
$16.44

Technical Indicators

Market Signals
Indicator
SUPN
APLE
Relative Strength Index (RSI) 45.90 49.38
Support Level $45.36 $11.46
Resistance Level $47.26 $11.94
Average True Range (ATR) 1.28 0.23
MACD 0.21 -0.02
Stochastic Oscillator 44.79 41.57

Price Performance

Historical Comparison
SUPN
APLE

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About APLE Apple Hospitality REIT Inc.

Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.

Share on Social Networks: